Dobbins, R., Hussey, E. K., O’Connor-Semmes, R., Andrews, S., Tao, W., Wilkison, W. O., . . . Hanmant, B. (2021). Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin. BMC Pharmacol Toxicol.

Dobbins, Robert, Elizabeth K. Hussey, Robin O’Connor-Semmes, Susan Andrews, Wenli Tao, William O. Wilkison, Bentley Cheatham, Katare Sagar, and Barkate Hanmant. "Assessment of Safety and Tolerability of Remogliflozin Etabonate (GSK189075) When Administered With Total Daily Dose of 2000 Mg of Metformin." BMC Pharmacol Toxicol 2021.

Dobbins, Robert, et al. "Assessment of Safety and Tolerability of Remogliflozin Etabonate (GSK189075) When Administered With Total Daily Dose of 2000 Mg of Metformin." BMC Pharmacol Toxicol 2021.